Drug Target Review2025-08-21T01:30:03
Researchers at UC San Diego have discovered a graphene-based technology that accelerates the maturation of human brain organoids, offering a safer, non-invasive way to model diseases like Alzheimer’s.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-06-02T15:00:00
Sponsored by Danaher
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, Drug Target Review
2026-09-23T15:00:00
Sponsored by BioIVT
2025-09-18T12:00:00
Sponsored by Benchling
2023-03-28T11:38:32
Sponsored by Bio-Techne
Site powered by Webvision Cloud